Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy"
- PMID: 38525846
- DOI: 10.1111/all.16104
Response to Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy"
Comment on
-
Correspondence to "Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy1".Allergy. 2024 Jun;79(6):1635-1636. doi: 10.1111/all.16020. Epub 2024 Jan 16. Allergy. 2024. PMID: 38226721 No abstract available.
References
REFERENCES
-
- Cheng IH, Yii CY, Shih LC, Yong SB. Correspondence to “short‐course subcutaneous treatment withPQGrass strongly improves symptom and medication scores in grass allergy1”. Allergy. 2024;79:1635‐1636. doi: 10.1111/all.16020. PMID: 38226721.
-
- de Kam PJ, Zielen S, Bernstein JA, et al. Short‐course subcutaneous treatment with PQ grass strongly improves symptom and medication scores in grass allergy. Allergy. 2023;78:2756‐2766.
-
- Starchenka S, Oluwayi K, Heath M, et al. Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy. Clin Exp Allergy. 2024;54:130‐142.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources